• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Hamilton Lane Incorporated filed SEC Form 8-K: Other Events

    2/20/26 4:15:21 PM ET
    $HLNE
    Investment Managers
    Finance
    Get the next $HLNE alert in real time by email
    hlne-20260220
    0001433642false00014336422026-02-202026-02-20


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): February 20, 2026
    Hamilton Lane Incorporated
    (Exact Name of Registrant as specified in its charter)
    Delaware001-3802126-2482738
    (State or other jurisdiction of incorporation)
    (Commission File No.)(IRS Employer Identification No.)
    110 Washington Street,Suite 1300
    Conshohocken, PA19428
    (Address of principal executive offices)
    (Zip Code)
     (610) 934-2222 
    (Registrant’s telephone number, including area code)
    Not Applicable
    (Former Name or Former Address, if Changed Since Last Report)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐
     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Class A Common Stock, $0.001 par value per shareHLNEThe Nasdaq Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐



    Item 8.01. Other Events.

        As previously disclosed, on November 6, 2018, Hamilton Lane Incorporated (the “Company”) announced that the Company’s board of directors authorized a program to repurchase, in the aggregate, up to 6% of the outstanding shares of the Company’s Class A common stock as of the date of the authorization, not to exceed $50 million (the “Stock Repurchase Program”). The Company’s board of directors periodically reviews the Stock Repurchase Program and most recently re-approved it in December 2024.

        On February 20, 2026, the Company commenced repurchases under the Stock Repurchase Program. Repurchases made under the Stock Repurchase Program may be effectuated through the open market or in privately negotiated transactions from time to time based on market conditions and other factors. The Company has not previously repurchased any of its Class A common stock under the Stock Repurchase Program, so the full purchase authority remained available under this program prior to such repurchases. The total number of shares to be repurchased will be determined based on market conditions and other factors.




    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
    HAMILTON LANE INCORPORATED
    Date: February 20, 2026
    By:/s/ Lydia A. Gavalis
    Name:Lydia A. Gavalis
    Title:General Counsel and Secretary


    Get the next $HLNE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HLNE

    DatePrice TargetRatingAnalyst
    4/16/2026$166.00Neutral → Overweight
    Analyst
    12/11/2025$166.00Buy
    UBS
    11/6/2025$165.00Neutral → Buy
    Goldman
    10/14/2025$181.00Perform → Outperform
    Oppenheimer
    10/13/2025$150.00Mkt Perform → Outperform
    Keefe Bruyette
    10/3/2025$150.00Outperform
    BMO Capital Markets
    9/18/2025$162.00Sell → Neutral
    Goldman
    5/15/2025Outperform → Perform
    Oppenheimer
    More analyst ratings

    $HLNE
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Hamilton Lane Incorporated

    SCHEDULE 13D/A - Hamilton Lane INC (0001433642) (Subject)

    5/29/26 6:07:21 PM ET
    $HLNE
    Investment Managers
    Finance

    SEC Form 10-K filed by Hamilton Lane Incorporated

    10-K - Hamilton Lane INC (0001433642) (Filer)

    5/21/26 4:30:52 PM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Hamilton Lane INC (0001433642) (Filer)

    5/21/26 7:00:02 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    HAMILTON LANE INCORPORATED REPORTS FOURTH QUARTER AND FISCAL YEAR 2026 RESULTS

    CONSHOHOCKEN, Pa., May 21, 2026 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the fourth quarter and full fiscal year ended March 31, 2026. The Company issued a full detailed presentation of its fourth quarter and full fiscal year 2026 results, which can be accessed on the Company's Shareholders website at https://shareholders.hamiltonlane.com/.DividendHamilton Lane has declared a quarterly dividend of $0.60 per share of Class A common stock to record holders at the close of business on June 18, 2026 that will be paid on July 7, 2026. The target full-year dividend of $2.40 represents a 11% increase from t

    5/21/26 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)

    — Proven biopharmaceutical executive to lead commercial strategy as Cosette scales its branded pharmaceutical platform and advances its next phase of growth — Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today it has appointed David Bell as Chief Commercial Officer (Brands). David joins the company's executive leadership team as it continues to advance its ambitions in specialty pharmaceuticals and expand its commercial platform and portfolio. In this new role, David will oversee all branded commercial functions – including sales, marketing, market access, commercial operations, analytics, and portfolio strategy. He will be responsible

    5/19/26 8:12:00 AM ET
    $HLNE
    Investment Managers
    Finance

    MidOcean Announces Successful Close of Single-Asset Continuation Vehicle for Cloyes

    MidOcean Partners ("MidOcean"), a premier New York-based alternative asset manager specializing in middle-market private equity, alternative credit, and structured equity, today announced the closing of a single-asset continuation vehicle for Cloyes Gear and Products, Inc. ("Cloyes" or the "Company"), the North American leader and global designer, developer, manufacturer, and distributor of mission-critical timing drive systems and components for the automotive aftermarket. The continuation vehicle secured approximately $300 million in commitments, with funds managed by Hamilton Lane (NASDAQ:HLNE) serving as sole lead investor. In connection with the continuation vehicle, MidOcean-managed

    5/4/26 9:30:00 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Co-Chairman Rogers Hartley R. bought $9,992,338 worth of shares (110,932 units at $90.08) (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    5/28/26 4:54:55 PM ET
    $HLNE
    Investment Managers
    Finance

    Director Berkman David J bought $1,010,000 worth of shares (10,000 units at $101.00) (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    2/25/26 4:06:57 PM ET
    $HLNE
    Investment Managers
    Finance

    Co-Chief Executive Officer Hirsch Erik R. bought $988,260 worth of shares (9,225 units at $107.13), increasing direct ownership by 15% to 70,494 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    2/24/26 4:07:41 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hamilton Lane upgraded by Analyst with a new price target

    Analyst upgraded Hamilton Lane from Neutral to Overweight and set a new price target of $166.00

    4/16/26 7:58:32 AM ET
    $HLNE
    Investment Managers
    Finance

    UBS resumed coverage on Hamilton Lane with a new price target

    UBS resumed coverage of Hamilton Lane with a rating of Buy and set a new price target of $166.00

    12/11/25 9:09:19 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane upgraded by Goldman with a new price target

    Goldman upgraded Hamilton Lane from Neutral to Buy and set a new price target of $165.00

    11/6/25 8:41:24 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operating Officer Kramer Andrea Anigati was granted 3,605 shares, increasing direct ownership by 4% to 86,067 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    6/2/26 5:01:50 PM ET
    $HLNE
    Investment Managers
    Finance

    Chief Accounting Officer Carl Drew Thomas was granted 675 shares, increasing direct ownership by 58% to 1,846 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    6/2/26 4:56:22 PM ET
    $HLNE
    Investment Managers
    Finance

    Chief Financial Officer Armbrister Jeffrey Brian was granted 2,109 shares, increasing direct ownership by 19% to 12,958 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    6/2/26 4:48:51 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Leadership Updates

    Live Leadership Updates

    View All

    Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)

    — Proven biopharmaceutical executive to lead commercial strategy as Cosette scales its branded pharmaceutical platform and advances its next phase of growth — Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today it has appointed David Bell as Chief Commercial Officer (Brands). David joins the company's executive leadership team as it continues to advance its ambitions in specialty pharmaceuticals and expand its commercial platform and portfolio. In this new role, David will oversee all branded commercial functions – including sales, marketing, market access, commercial operations, analytics, and portfolio strategy. He will be responsible

    5/19/26 8:12:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Cosette Pharmaceuticals Appoints Erika Tooman as Senior Vice President, General Counsel, Strengthening Leadership Team to Drive Accelerated Growth and Strategic Expansion

    -- Experienced life sciences executive to lead legal, compliance, and governance as Cosette scales its platform following recent acquisitions and continued growth momentum -- Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today that it has appointed Erika Tooman as Senior Vice President and General Counsel, strengthening the company's executive leadership team as it advances its long‑term growth, portfolio expansion, and value‑creation strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429022652/en/ Erika brings more than two decades of experience guiding pharmaceutica

    4/29/26 8:15:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Leading asset managers to join new Corastone platform as investors alongside Apollo, Franklin Templeton and KKR

    Expanded institutional participation underscores growing demand for private market opportunities and standardized operating infrastructureNEW YORK, March 9, 2026 /PRNewswire/ -- Corastone, the hyperscaler for private-market investing, today announced Fidelity Investments, Future Standard, and Hamilton Lane (NASDAQ:HLNE) as investors in Corastone and its alternative-investing operating platform. This growing institutional participation builds on Corastone's recent platform launch and comes as demand for private markets investments expands across investor types. As global private

    3/9/26 9:05:00 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Financials

    Live finance-specific insights

    View All

    HAMILTON LANE INCORPORATED REPORTS FOURTH QUARTER AND FISCAL YEAR 2026 RESULTS

    CONSHOHOCKEN, Pa., May 21, 2026 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the fourth quarter and full fiscal year ended March 31, 2026. The Company issued a full detailed presentation of its fourth quarter and full fiscal year 2026 results, which can be accessed on the Company's Shareholders website at https://shareholders.hamiltonlane.com/.DividendHamilton Lane has declared a quarterly dividend of $0.60 per share of Class A common stock to record holders at the close of business on June 18, 2026 that will be paid on July 7, 2026. The target full-year dividend of $2.40 represents a 11% increase from t

    5/21/26 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Incorporated to Announce Fourth Fiscal Quarter and Full Fiscal Year 2026 Results on May 21, 2026

    CONSHOHOCKEN, Pa., April 23, 2026 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the fourth fiscal quarter and full fiscal year ended March 31, 2026 before the market opens on Thursday, May 21, 2026. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website. Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on May 21 to discuss the results for the fourth fiscal quarter and full fiscal year. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here at least 15 minutes prior to the start of the call. This f

    4/23/26 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Announces Strategic Investment in Republic

    CONSHOHOCKEN, Pa. and NEW YORK, March 17, 2026 /PRNewswire/ -- Hamilton Lane (NASDAQ:HLNE), a leading global private markets investment firm, today announced a strategic investment in Republic, a leading on-chain global investment platform, reinforcing the firms' shared commitment to expanding retail investor access to institutional-quality private market funds. The investment builds on the existing partnership between Hamilton Lane and Republic, and underscores Hamilton Lane's long-term strategy to modernize and expand access to private markets. Together, the firms are enabling broader participation in the private markets asset class, which has historically been limited to institutions and

    3/17/26 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/13/24 9:56:40 PM ET
    $HLNE
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/12/24 3:55:46 PM ET
    $HLNE
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/4/24 11:53:29 AM ET
    $HLNE
    Investment Managers
    Finance